[1]李潇然,杨星昊.痛泻要方潜在活性成分的分子靶向对接虚拟筛选研究[J].南京师范大学学报(自然科学版),2018,41(03):85.[doi:10.3969/j.issn.1001-4616.2018.03.014]
　Li Xiaoran,Yang Xinghao.Study on the Molecular Targeting Docking Virtual Screening ofPotential Active Components in Tong-Xie-Yao-Fang[J].Journal of Nanjing Normal University(Natural Science Edition),2018,41(03):85.[doi:10.3969/j.issn.1001-4616.2018.03.014]
点击复制

痛泻要方潜在活性成分的分子靶向对接虚拟筛选研究()
分享到：

《南京师范大学学报》（自然科学版）[ISSN:1001-4616/CN:32-1239/N]

卷:
第41卷
期数:
2018年03期
页码:
85
栏目:
·生命科学·
出版日期:
2018-09-30

文章信息/Info

Title:
Study on the Molecular Targeting Docking Virtual Screening ofPotential Active Components in Tong-Xie-Yao-Fang
文章编号:
1001-4616(2018)03-0085-10
作者:
李潇然; 杨星昊
南京师范大学生命科学学院,新药研究中心,江苏 南京 210023
Author(s):
Li Xiaoran; Yang Xinghao
School of Life Sciences,Nanjing Normal University,New Drug Research Center,Nanjing 210023,China
关键词:
痛泻要方; 分子靶向对接; 肠易激综合征
Keywords:
Tong-Xie-Yao-Fang; targeting docking; irritable bowel syndrome
分类号:
R285
DOI:
10.3969/j.issn.1001-4616.2018.03.014
文献标志码:
A
摘要:
肠易激综合征(IBS)新型药物靶标,应用分子靶向对接技术从痛泻要方化学成分中虚拟筛选具有活性潜力的天然小分子. 创建了包含239种化合物的痛泻要方活性成分数据库,以色氨酸羟化酶1(TPH1),5-羟色胺跨膜转运蛋白(SERT),促肾上腺皮质激素释放因子受体1(CRFR1)和瞬时受体电位香草酸受体1(TRPV1)为对象,采用配体库构建、受体蛋白准备、对接位点研究、对接参数设定、分子对接批量打分、结合模式分析、相互作用分析、药效团分析的虚拟筛选流程. 结果显示,123种天然成分显示了良好的配体-受体结合作用潜力,呈现“单靶点,多配体”的特征; Paeoniflorin、Deltoin、Naringin和β-Vatirenene等天然成分具有“单配体,多靶点”的潜力. 4-O-methyl-paeoniflorin、iso-Paeoniflorin和Gallotannin; iso-Benzoylpaeoniflorin、iso-Paeoniflorin和Benzoylpaeoniflorin; Paeoniflorin、Albiflorin R1和Albiflorin; Deltoin、Galloylpaeoniflorin、Galloylpaeoniflorine和Benzoylpaeoniflorin等13个化合物为最具潜力天然成分. 药效团模型分析揭示,TPH1配体包含了2个氢键受体和3个氢键给体,SERT配体包含4个氢键受体、2个氢键给体和1个疏水中心; CRFR1配体包含1个氢键受体、2个氢键给体和 1个疏水中心,TRPV1配体包含3个氢键受体和 1个疏水中心. 本研究为IBS治疗药物开发提供了候选化合物,并从分子水平上阐明痛泻要方作用机制提供了参考.
Abstract:
This study was based on a novel drug target of irritable bowel syndrome(IBS)and used molecular targeted docking technology to virtually screen promising natural small molecules from Tong-Xie-Yao-Fang. The active compound database of Tong-Xie-Yao-Fang was created,which contained a total of 239 compounds. And four proteins were selected as the targets including Tryptophan Hydroxylase 1(TPH1),Serotonin Transporter(SERT),Corticotropin Releasing Factor Receptor 1(CRFR1),and Transient Receptor Potential Vanilloid Receptor 1(TRPV1). The whole process covers the ligands database construction,receptor protein preparation,docking site study,docking parameter setting,molecular docking batch scoring,binding mode analysis,interaction analysis,and pharmacophore analysis virtual screening process. The results showed that 123 of the natural compounds docked with the receptor scored the first 30% showing good ligand-receptor interaction,they present the characteristics of "single target,multiple ligands". This study also found that Paeoniflorin in the Paeoniae Radix Alba,Deltoin in the Radix Saposhnikoviae Divaricatae,Naringin in the Pericarpium Citri Reticulatae,and β-Vatirenene in the Atractylodes Macrocephala have the most“single component,multiple targets”therapeutic potential. The results showed that 13 compounds including 4-O-methyl-paeoniflorin,iso-Paeoniflorin and Gallotannin; iso-Benzoylpaeoniflorin,iso-Paeoniflorin and Benzoylpaeoniflorin; Paeoniflorin,Albiflorin R1and Albiflorin; Deltoin,Galloylpaeoniflorin,Galloylpaeoniflorine and Benzoylpaeoniflorin were the most promising natural compounds. The pharmacophore model analysis showed that the TPH1 ligand contained two hydrogen bond acceptors and three hydrogen bond donors. The SERT ligand contained four hydrogen bond acceptors,two hydrogen bond donors and one hydrophobic center. CRFR1 contained one hydrogen bond acceptor,two hydrogen bond donors and one hydrophobic center. TRPV1 contained three hydrogen bond acceptors and one hydrophobic center. 12 potential compounds were achieved through the screening process above. This study provides candidate compounds for the development of IBS therapeutic drugs and reference for exploring the molecular mechanism of Tong-Xie-Yao-Fang.

参考文献/References:

[1] TORPY J M,LYNM C,GLASS R M. Irritable bowel syndrome[J]. Journal of the American medical association,2004,292(7):886.
[2]SALVIOLI B,PELLEGATTA G,MALACARNE M,et al. Autonomic nervous system dysregulation in irritable bowel syndrome[J]. Neurogastroenterol motil,2015,27(3):423-430.
[3]DUNLOP S P,JENKINS D,NEAL K R,et al. Relative importance of enterochromaffin cell hyperplasia,anxiety,and depression in postinfectious IBS[J]. Gastroenterology,2003,125(6):1651-1659.
[4]TACH Y,MILLION M,NELSON A G,et al. Role of corticotropin-releasing factor pathways in stress-related alterations of colonic motor function and viscerosensibility in female rodents[J]. Gender medicine,2005,2(3):146-154.
[5]BOESMANS W,OWSIANIK G,TACK J,et al. TRP channels in neurogastroenterology:opportunities for therapeutic intervention[J]. British journal of pharmacology,2011,162(1):18-37.
[6]BRADESI S,TILLISCH K,MAYER E. Emerging drugs for irritable bowel syndrome[J]. Expert opinion on emerging drugs,2006,11(2):293-313.
[7]CHIAL H J,CAMILLERI M,FERBER I,et al. Effects of venlafaxine,buspirone,and placebo on colonic sensorimotor functions in healthy humans[J]. Clin Gastroenterol Hepatol,2003,1(3):211-218.
[8]SHEKHAR C,WHORWELL P J. Emerging drugs for irritable bowel syndrome[J]. Expert opinion on emerging drugs,2009,14(4):673-685.
[9]薛丽君,杨怡玲,唐剑,等. 肠易激综合征的药物治疗进展[J]. 医学综述,2016(1):118-121.
[10]唐丽明,宋宁,袁红霞. 中药复方治疗肠易激综合征的实验研究进展[J]. 中国实验方剂学,2013(19):355-360.
[11]缪乐涛,张婧娴,芮俊乾,等. 基于系统药理学探索痛泻要方治疗肠易激综合征的分子机制[J]. 中国现代中药,2017,19(11):1555-1561.
[12]HEROWATI R,WIDODO G P. Molecular docking studies of chemical constituents of Tinospora cordifolia on glycogen phosphorylase[J]. Procedia chemistry,2014,13:63-68.
[13]CHEN C Y. Computational screening and design of Traditional Chinese Medicine(TCM)to block phosphodiesterase-5[J]. Journal of molecular graphics & modelling,2009,28(3):261-269.
[14]CHOI R J,ROY A,JUNG H J,et al. BACE1 molecular docking and anti-Alzheimer’s disease activities of ginsenosides[J]. Journal of ethnopharmacology,2016,190:219-230.
[15]CHEN C Y C. TCM Database@ Taiwan:the world’s largest traditional Chinese medicine database for drug screening in silico[J]. PloS one,2011,6(1):e15939.
[16]XIANG L,XU Y,ZHANG Y,et al. Virtual screening studies of Chinese medicine Coptidis Rhizoma as alpha7 nicotinic acetylcholine receptor agonists for treatment of Alzheimer’s disease[J]. Journal of molecular structure,2015,1086:207-215.
[17]XING,TIAN,JIAN,et al. 1,5-O-Dicaffeoyl-quinic Acid as a novel potential NMDA receptor inhibitor from traditional Chinese medicine database by virtual screening[J]. Chinese herbal medicines,2016,8(4):366-370.
[18]GRASBERGER H,CHANG L,SHIH W,et al. Identification of a functional TPH1 polymorphism associated with irritable bowel syndrome bowel habit subtypes[J]. American journal of gastroenterology,2013,108(11):1766-1774.
[19]GEERAERTS B,OUDENHOVE L V,TACK J. Serotonin transporter gene polymorphisms in irritable bowel syndrome[J]. Neurogastroenterology & motility the official journal of the european gastrointestinal motility society,2010,18(11):957-959.
[20]SAGAMI Y,SHIMADA Y,TAYAMA J,et al. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome[J]. Gut,2004,53(7):958-964.
[21]LARAUCHE M,GOURCEROL G,WANG L,et al. Cortagine,a CRF1 agonist,induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways[J]. Ajp gastrointestinal & liver physiology,2009,297(1):215-227.
[22]AKBAR A,YIANGOU Y,FACER P,et al. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain[J]. Gut,2008,57(7):923-929.
[23]NAGY I,S NTHA P,JANCS G,et al. The role of the vanilloid(capsaicin)receptor(TRPV1)in physiology and pathology[J]. European journal of pharmacology,2004,500(1):351-369.
[24]林震群,张维波,周文博. 痛泻要方颗粒对腹泻型肠易激综合征的结肠黏膜5-HT3受体表达的影响[J]. 福建中医药,2011,42(5):14-16.
[25]晁冠群,吕宾,孟立娜,等. 痛泻要方对内脏高敏感大鼠脑、脊髓CRF表达的影响[J]. 中国中药,2010(15):2012-2016.
[26]吴嫣然. 痛泻要方对慢性应激导致的内脏高敏感和肠道动力异常的作用及机制研究[D]. 武汉:华中科技大学,2016.
[27]LIPINSKI C A. Lead-and drug-like compounds:the rule-of-five revolution[J]. Drug discovery today technologies,2004,1(4):337-341.
[28]YU J,ZHOU Y,TANAKA I,et al. Roll:a new algorithm for the detection of protein pockets and cavities with a rolling probe sphere[J]. Bioinformatics,2010,26(1):46-52.

备注/Memo

备注/Memo:
收稿日期:2018-05-08.
基金项目:江苏省高校自然科学研究重大项目(15KJA360001).
通讯联系人:杨星昊,教授,研究方向:中药物质基础研究. E-mail:yangxinh@126.com
更新日期/Last Update: 2018-11-19